Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in Netherlands
58 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Not yet taking people in NetherlandsEPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
- Where
- Amsterdam, Groningen
- Age
- 18 years and over
- People
- 55 worldwide
- Run by
- Medigene AG
See details and how to joinNCT06748872 · EU 2024-516787-28-00 - Phase 3WithdrawnPROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
- Where
- Groningen, Maastricht
- Age
- 18 years and over
- People
- 396 worldwide
- Run by
- University of Aarhus
See details and how to joinNCT05055648 - No phaseTaking peopleTGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 49
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT04481256 - No phaseTaking peoplePrediction Models for Complications After CRT in Esophageal Cancer
- Where
- Amsterdam, Delft, Groningen, Heerlen, Maastricht, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years to 100 years
- People
- 2,000
- Run by
- University Medical Center Groningen
See details and how to joinNCT06366828 - No phaseTaking peopleStandard Follow-Up Program (SFP) for Patients With Esophageal Cancer
- Where
- Groningen
- Age
- 18 years and over
- People
- 10,000
- Run by
- University Medical Center Groningen
See details and how to joinNCT02454790 - No phaseTaking peopleSurgery As Needed for Oesophageal Cancer - 2
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 360
- Run by
- Bas P. L. Wijnhoven
See details and how to joinNCT04886635 - No phaseTaking peopleDistribution of Lymph Node Metastases in Esophageal Carcinoma
- Where
- Almelo, Amsterdam
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT03222895 - Phase 3Taking peopleTRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 376
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT05188313